Curevac N.V. (CVAC)
$7.60
0.10 (1.30%)
CVAC Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We've got another busy day of trading ahead of us so let's get right to it with the biggest pre-market stock movers for Wednesday!
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
232,870
Day's Range
$7.53 - $7.73
52-Week Range
$6.81 - $45.23
Dividend & Yield
N/A (N/A)
CVAC Stock Predictions, Articles, and Curevac N.V. News
Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks Today
Today, investors in vaccine stocks are seeing a lot of red, as investors seem to be taking some risk off the table ahead of Fed tapering.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading for the week and we're kicking it off right with a look at the pre-market stock movers for Friday!
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on a World Bank decision and big moves in RIDE and CVAC stocks.
CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today
CureVac shares crashed after the German biotech said its Covid-19 vaccine was only 47% effective in preventing the disease.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the biggest pre-market stock movers for Thursday and it includes loads of medical stocks.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're really starting to get into earnings season with many of the biggest pre-market stock movers today connected to earnings news.
CVAC Stock: CureVac Pops on Plans for Phase 2 Vaccine Trials
CureVac just announced it was launching Phase 2 trials in Peru and Panama for its coronavirus vaccine. CVAC stock is rallying in response.
Germany Makes a $299 Million Bet on CureVac
CureVac recently was awarded $299 million to support the development of its Covid-19 vaccine. What does this mean for CureVac stock?
CureVac Stock Is Just Another Part of a Bigger Story
With its Covid-19 vaccine candidate, CureVac stock soared after its IPO in August. But as Operation Warp Speed wraps up, investors may wonder if there's anything else.
No Need to Rush Into CureVac Stock After Massive IPO Pop
CVAC stock is one of many intriguing plays on a Covid-19 vaccine. But 300% above the IPO price, investors seemingly have better options.
Why Science and Economics Might Justify CureVac
Amid a sea of red ink in the Covid-19 vaccine space, CureVac stock has gone against the grain, printing some sizable gains. Can investors trust the momentum for CureVac?
Is CureVac a Buy on the Pullback? It Depends
Recent IPO and vaccine play CureVac stock could bounce back – but tread carefully. Much of the upside remains priced into shares.
Why CureVac Might Soar From Here
The coronavirus vaccine play is crowded and CureVac stock needs to win more deals to get noticed
Go Easy on CureVac Stock After Its Red-Hot Market Debut
CureVac stock has been hot since its IPO thanks to its coronavirus vaccine candidate. Here's why you should give CVAC a breather now.
